Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia — Stella

Home/Postherpetic Neuralgia/Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia

View on ClinicalTrials.gov

Recruiting

Back to Postherpetic Neuralgia trials

Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Beijing Tiantan Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Beijing Tiantan Hospital

Collaborators

Beijing Xiaotangshan Hospital, The First Hospital of Fangshan District,Beijing

Enrollment target

~150 participants

Started

April 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.